Tuning A Repurposed
Biotech: Balancing Personal & Company Growth
Anna Ressa | CEO and co-founder, Pepscope
Anna Ressa is the CEO and co-founder of Pepscope. She joined Pepscope in 2018 as Scientific Lead in mass spectrometry, bringing over eight years of experience in academic and industrial R&D, including Nerviano Medical Sciences. In 2018, Anna took the initiative for a strategic partnership between Pepscope and Utrecht University, resulting in the adoption of QuantaKinome™ technology. She has led the Pepscope team since 2019, playing a crucial role in completing a successful investment in 2020. Anna obtained her Ph.D. at Utrecht University in the Biomolecular Mass Spectrometry & Proteomics group, has a cum laude M.Sc. in Chemistry from the University of Bologna, and a degree in Cancer Pharmacology from the University of Milan.
At Pepscope, we deliver next-generation tools to truly understand kinome activity.
We help researchers who get stuck in drug discovery and development by designing and creating tailor-made solutions for a clearer molecular understanding of biology in several human models. Our innovative biotechnology serves as a platform to enable the identification of new combination therapy, repurpose drugs, and discover biomarkers.
Our vision is to bring medicines to patients faster by helping you get the right insights. We take pride in supporting our customers with unique compound insights, passion, and a firm commitment to adhere to the highest quality standards.
Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | |
|
© Copyright 2020 by Hyphen Projects